Belgian Lung Function Study

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorKU Leuven

About this trial

Currently, it remains unclear how to manage serial lung function measurements in a clinical setting. The investigators aimed to tackle this problem by developing a machine learning (ML) model that can accurately predict population and individual lung function trajectories. These predictions would enable the investigators to identify positive or negative deviations, thereby revealing unexpected disease patterns.

A prospective validation is needed that includes data on mortality, hospitalisations, emergency-room visits and patient-reported outcomes. Within this study, the goal is to validate the ML model with the data collected from this observational study.

Eligibility criteria

Qualifiers

Above 18 years old

Diagnosed with a chronic respiratory disease and followed up in one of the participating Belgian hospitals

Performed a complete lung function test (spirometry, body plethysmography and diffusion capacity) at baseline

Have at least 3 historical spirometry measurements over a minimal time window of 2 years prior to inclusion

Disqualifiers

Patients who have had a lung transplantation

Patients not being able to give consent to participate

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Sponsors and collaborators

KU Leuven

Lead sponsor

AZ Delta

Collaborator

University Hospital, Antwerp

Collaborator

Ziekenhuis Oost-Limburg

Collaborator